• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA结合蛋白IMP3通过下调应激诱导配体ULPB2和MICB促进肿瘤免疫逃逸。

The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.

作者信息

Schmiedel Dominik, Tai Julie, Yamin Rachel, Berhani Orit, Bauman Yoav, Mandelboim Ofer

机构信息

The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, Israel.

出版信息

Elife. 2016 Mar 16;5:e13426. doi: 10.7554/eLife.13426.

DOI:10.7554/eLife.13426
PMID:26982091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4805531/
Abstract

Expression of the stress-induced ligands MICA, MICB and ULBP 1-6 are up-regulated as a cellular response to DNA damage, excessive proliferation or viral infection; thereby, they enable recognition and annihilation by immune cells that express the powerful activating receptor NKG2D. This receptor is present not exclusively, but primarily on NK cells. Knowledge about the regulatory mechanisms controlling ULBP expression is still vague. In this study, we report a direct interaction of the oncogenic RNA binding protein (RBP) IMP3 with ULBP2 mRNA, leading to ULBP2 transcript destabilization and reduced ULBP2 surface expression in several human cell lines. We also discovered that IMP3 indirectly targets MICB with a mechanism functionally distinct from that of ULBP2. Importantly, IMP3-mediated regulation of stress-ligands leads to impaired NK cell recognition of transformed cells. Our findings shed new light on the regulation of NKG2D ligands and on the mechanism of action of a powerful oncogenic RBP, IMP3.

摘要

应激诱导配体MICA、MICB和ULBP 1 - 6的表达上调,作为细胞对DNA损伤、过度增殖或病毒感染的反应;因此,它们能够被表达强大激活受体NKG2D的免疫细胞识别并清除。该受体并非仅存在于NK细胞上,而是主要存在于NK细胞上。关于控制ULBP表达的调控机制仍不明确。在本研究中,我们报道了致癌性RNA结合蛋白(RBP)IMP3与ULBP2 mRNA的直接相互作用,导致ULBP2转录本不稳定,并降低了几种人类细胞系中ULBP2的表面表达。我们还发现IMP3通过一种功能上不同于ULBP2的机制间接靶向MICB。重要的是,IMP3介导的应激配体调控导致NK细胞对转化细胞的识别受损。我们的发现为NKG2D配体的调控以及强大的致癌性RBP IMP3的作用机制提供了新的线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/d0a66e84da2d/elife-13426-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/16380d0e6e74/elife-13426-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/dfa5e9096e9f/elife-13426-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/0a082c01eedf/elife-13426-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/1e9e2b734b3c/elife-13426-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/9ba25a87b271/elife-13426-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/05cbbfe59207/elife-13426-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/067eeea8fd8a/elife-13426-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/994ed6109024/elife-13426-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/6daf49b8dbf4/elife-13426-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/49519ce95609/elife-13426-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/d0a66e84da2d/elife-13426-fig8-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/16380d0e6e74/elife-13426-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/dfa5e9096e9f/elife-13426-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/0a082c01eedf/elife-13426-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/1e9e2b734b3c/elife-13426-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/9ba25a87b271/elife-13426-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/05cbbfe59207/elife-13426-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/067eeea8fd8a/elife-13426-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/994ed6109024/elife-13426-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/6daf49b8dbf4/elife-13426-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/49519ce95609/elife-13426-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec1/4805531/d0a66e84da2d/elife-13426-fig8-figsupp1.jpg

相似文献

1
The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.RNA结合蛋白IMP3通过下调应激诱导配体ULPB2和MICB促进肿瘤免疫逃逸。
Elife. 2016 Mar 16;5:e13426. doi: 10.7554/eLife.13426.
2
Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.可溶性 NKG2D 受体配体在 HIV-1 感染过程中释放,并损害 NK 细胞的 NKG2D 表达和细胞毒性。
FASEB J. 2013 Jun;27(6):2440-50. doi: 10.1096/fj.12-223057. Epub 2013 Feb 8.
3
Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.人巨细胞病毒感染对自然杀伤细胞(NK细胞)激活型NKG2D受体配体的影响:病毒UL16蛋白可抵消UL16结合蛋白(ULBP)1和ULBP2的上调。
J Immunol. 2003 Jul 15;171(2):902-8. doi: 10.4049/jimmunol.171.2.902.
4
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.通过去甲基化剂增加TIMP3表达可减少急性髓系白血病中可溶性MICA、MICB和ULBP2的脱落,促进自然杀伤细胞介导的免疫识别。
Oncotarget. 2017 May 9;8(19):31959-31976. doi: 10.18632/oncotarget.16657.
5
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.作为人类神经母细胞瘤免疫逃逸策略的NKG2D配体下调和/或释放
Neoplasia. 2004 Sep-Oct;6(5):558-68. doi: 10.1593/neo.04316.
6
Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.干扰素-γ下调NKG2D配体的表达,并损害自然杀伤细胞对MHC I类缺陷型黑色素瘤的NKG2D介导的细胞溶解作用。
Int J Cancer. 2009 Apr 1;124(7):1594-604. doi: 10.1002/ijc.24098.
7
Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.NKG2D 及其配体的上调表达为胸腺瘤患者提供了潜在的治疗靶点。
Cancer Gene Ther. 2015 Jul;22(7):368-74. doi: 10.1038/cgt.2015.29. Epub 2015 Jun 26.
8
Vigilin Regulates the Expression of the Stress-Induced Ligand MICB by Interacting with Its 5' Untranslated Region.vigilin通过与其5'非翻译区相互作用来调节应激诱导配体MICB的表达。
J Immunol. 2017 May 1;198(9):3662-3670. doi: 10.4049/jimmunol.1601589. Epub 2017 Mar 29.
9
c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.c-Cbl 调节人 NK 细胞中由 MICA 而非 ULBP2 诱导的 NKG2D 下调。
Eur J Immunol. 2014 Sep;44(9):2761-70. doi: 10.1002/eji.201444512. Epub 2014 Jun 17.
10
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.可溶性ULBP通过下调NKG2D表达来抑制自然杀伤细胞活性。
Cell Immunol. 2006 Jan;239(1):22-30. doi: 10.1016/j.cellimm.2006.03.002. Epub 2006 Apr 21.

引用本文的文献

1
Systematic analysis of IGF2BP family members in non-small-cell lung cancer.非小细胞肺癌中IGF2BP家族成员的系统分析。
Hum Genomics. 2024 Jun 12;18(1):63. doi: 10.1186/s40246-024-00632-6.
2
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma.IGF2BP3作为高分化/去分化脂肪肉瘤的预后生物标志物
Cancers (Basel). 2023 Sep 9;15(18):4489. doi: 10.3390/cancers15184489.
3
IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8 T Cells in the Tumor Microenvironment.

本文引用的文献

1
Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.癌胚抗原IGF2BP3在结直肠癌中的表达;IGF2BP3有望成为一种特异性免疫治疗靶点。
Oncoscience. 2015 Jul 1;2(6):607-14. doi: 10.18632/oncoscience.174. eCollection 2015.
2
A census of human RNA-binding proteins.人类 RNA 结合蛋白普查。
Nat Rev Genet. 2014 Dec;15(12):829-45. doi: 10.1038/nrg3813. Epub 2014 Nov 4.
3
Cellular differences in protein synthesis regulate tissue homeostasis.蛋白质合成中的细胞差异调节组织稳态。
IGF2BP3通过调节肿瘤微环境中巨噬细胞和CD8 T细胞的特性来促进肝细胞癌肿瘤生长。
J Clin Transl Hepatol. 2023 Nov 28;11(6):1308-1320. doi: 10.14218/JCTH.2023.00184. Epub 2023 Aug 1.
4
IGF2BPs as novel mA readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment.IGF2BPs作为新型的m⁶A阅读器:在调节癌细胞生物学功能、缺氧适应、代谢和免疫抑制性肿瘤微环境中的多种作用。
Genes Dis. 2023 Jul 20;11(2):890-920. doi: 10.1016/j.gendis.2023.06.017. eCollection 2024 Mar.
5
Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial mA regulators of tumors.胰岛素样生长因子 2 mRNA 结合蛋白的调控机制及其治疗意义,作为新兴的关键 mA 调控因子在肿瘤中的作用。
Theranostics. 2023 Jul 24;13(12):4247-4265. doi: 10.7150/thno.86528. eCollection 2023.
6
IMP3 promotes re-endothelialization after arterial injury via increasing stability of VEGF mRNAhv.IMP3 通过增加 VEGF mRNAhv 的稳定性促进动脉损伤后的再内皮化。
J Cell Mol Med. 2022 Apr;26(7):2023-2037. doi: 10.1111/jcmm.17225. Epub 2022 Mar 22.
7
Comprehensive analysis of N-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer.膀胱癌中N-甲基腺苷调节剂与肿瘤免疫景观的综合分析以及胰岛素样生长因子2 mRNA结合蛋白3与程序性死亡配体1之间的相关性
Cancer Cell Int. 2022 Feb 11;22(1):72. doi: 10.1186/s12935-022-02456-7.
8
RNA N -methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential.RNA N -甲基腺苷修饰在癌症干细胞与肿瘤免疫微环境的致命协作中的作用:现状与治疗潜力。
Clin Transl Med. 2021 Sep;11(9):e525. doi: 10.1002/ctm2.525.
9
Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity.利用 CRISPR 操纵 NKG2D 受体-配体轴:提高宿主免疫的新技术。
Front Immunol. 2021 Aug 12;12:712722. doi: 10.3389/fimmu.2021.712722. eCollection 2021.
10
Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma.RNA甲基化N6-甲基腺苷调节剂对黑色素瘤恶性进展及预后的影响。
Cancer Cell Int. 2021 Aug 26;21(1):453. doi: 10.1186/s12935-021-02163-9.
Cell. 2014 Oct 9;159(2):242-51. doi: 10.1016/j.cell.2014.09.016.
4
RNA-binding proteins regulate the expression of the immune activating ligand MICB.RNA结合蛋白调节免疫激活配体MICB的表达。
Nat Commun. 2014 Jun 13;5:4186. doi: 10.1038/ncomms5186.
5
Post-transcriptional coordination of immunological responses by RNA-binding proteins.RNA 结合蛋白对免疫反应的转录后协调。
Nat Immunol. 2014 Jun;15(6):492-502. doi: 10.1038/ni.2884.
6
IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma.IMP3 表达与肝内胆管癌不良预后和表观遗传失调相关。
Hum Pathol. 2014 Jun;45(6):1184-91. doi: 10.1016/j.humpath.2014.01.016. Epub 2014 Feb 6.
7
Role of IGF2BP3 in trophoblast cell invasion and migration.IGF2BP3 在滋养层细胞侵袭和迁移中的作用。
Cell Death Dis. 2014 Jan 23;5(1):e1025. doi: 10.1038/cddis.2013.545.
8
Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.胰岛素样生长因子-II mRNA结合蛋白3预示着结肠腺癌的预后不良。
Oncol Lett. 2013 Sep;6(3):740-744. doi: 10.3892/ol.2013.1458. Epub 2013 Jul 12.
9
Expression of insulin-like growth factor II mRNA-binding protein 3 (IMP3) in sacral chordoma.胰岛素样生长因子 II mRNA 结合蛋白 3(IMP3)在骶骨脊索瘤中的表达。
J Neurooncol. 2014 Jan;116(1):77-82. doi: 10.1007/s11060-013-1274-4. Epub 2013 Oct 18.
10
At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.床边诊疗:固有免疫作为血液系统恶性肿瘤免疫疗法的工具。
J Leukoc Biol. 2013 Dec;94(6):1141-57. doi: 10.1189/jlb.0613343. Epub 2013 Oct 4.